Clinical advances in viral-vectored influenza vaccines

Clinical advances in viral-vectored influenza vaccines

Influenza-virus-mediated disease can be associated with high levels of morbidity and mortality, particularly in younger children and older adults. Vaccination is the primary intervention used to curb influenza virus infection, and the WHO recommends immunization for at-risk individuals to mitigate d...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sebastian, S, Lambe, T
Formáid:	Journal article
Foilsithe / Cruthaithe:	MDPI 2018

Míreanna comhchosúla

Clinical Advances in Viral-Vectored Influenza Vaccines
de réir: Sarah Sebastian, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Viral vector vaccines
de réir: McCann, N, et al.
Foilsithe / Cruthaithe: (2022)

Clinical development of viral vectored vaccines against MERS-COV
de réir: Ewer, K, et al.
Foilsithe / Cruthaithe: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
de réir: D. A. Mezhenskaia, et al.
Foilsithe / Cruthaithe: (2018-12-01)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
de réir: Bissett, C, et al.
Foilsithe / Cruthaithe: (2024)

Viral vectors as vaccine platforms: from immunogenicity to impact
de réir: Ewer (nee Russell), K, et al.
Foilsithe / Cruthaithe: (2016)

Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine
de réir: Cameron Bissett, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
de réir: Arunkumar, G, et al.
Foilsithe / Cruthaithe: (2019)

Research advances in replication-deficient viral vector vaccines
de réir: Junna Wang, et al.
Foilsithe / Cruthaithe: (2025-03-01)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
de réir: McMahon, M, et al.
Foilsithe / Cruthaithe: (2019)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
de réir: Antrobus, R
Foilsithe / Cruthaithe: (2014)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
de réir: Tully, C, et al.
Foilsithe / Cruthaithe: (2017)

Towards the development of a universal influenza vaccine: investigating viral-vectored vaccine-induced heterosubtypic immune responses to influenza A
de réir: Tully, C
Foilsithe / Cruthaithe: (2015)

Development of viral vectors for passive immunisation against influenza
de réir: Tan, TK
Foilsithe / Cruthaithe: (2017)

Evaluating the potential of novel virus-vectored vaccines as intranasal vaccine candidates for broad immunity against influenza
de réir: Mullin, J, et al.
Foilsithe / Cruthaithe: (2014)

Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral Vector
de réir: Irina Isakova-Sivak, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
de réir: Marta Ulaszewska, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
de réir: Antrobus, R, et al.
Foilsithe / Cruthaithe: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
de réir: Antrobus, R, et al.
Foilsithe / Cruthaithe: (2014)

Adenoviral vectors as novel vaccines for influenza.
de réir: Coughlan, L, et al.
Foilsithe / Cruthaithe: (2015)

Viral vectors for malaria vaccine development.
de réir: Li, S, et al.
Foilsithe / Cruthaithe: (2007)

The use of viral vectors in vaccine development
de réir: Tatianna Travieso, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Replicon RNA Viral Vectors as Vaccines
de réir: Kenneth Lundstrom
Foilsithe / Cruthaithe: (2016-11-01)

Developments in Viral Vector-Based Vaccines
de réir: Takehiro Ura, et al.
Foilsithe / Cruthaithe: (2014-07-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
de réir: Ewer (nee Russell), K, et al.
Foilsithe / Cruthaithe: (2017)

Pre-clinical development of viral vectored transmission-blocking malaria vaccines
de réir: Kapulu, MC
Foilsithe / Cruthaithe: (2014)

Recombinant influenza A viruses as vaccine vectors
de réir: Thomas Gerlach, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Viral vectors as vaccine platforms: Deployment in sight
de réir: Rollier, C, et al.
Foilsithe / Cruthaithe: (2011)

Novel viral vector vaccines for tropical infections
de réir: Rampling, T
Foilsithe / Cruthaithe: (2017)

Viral vectors as vaccine platforms: deployment in sight.
de réir: Rollier, C, et al.
Foilsithe / Cruthaithe: (2011)

Viral Vectors for COVID-19 Vaccine Development
de réir: Kenneth Lundstrom
Foilsithe / Cruthaithe: (2021-02-01)

Viral Vector Vaccines against Bluetongue Virus
de réir: Luis Jiménez-Cabello, et al.
Foilsithe / Cruthaithe: (2020-12-01)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
de réir: Katie Ewer, et al.
Foilsithe / Cruthaithe: (2017-12-01)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
de réir: Sushmita Kumari, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines
de réir: Jianfeng Zhang
Foilsithe / Cruthaithe: (2012-11-01)

Advances in Adjuvanted Influenza Vaccines
de réir: Shintaro Shichinohe, et al.
Foilsithe / Cruthaithe: (2023-08-01)

Approaches to quality control, preclinical and clinical studies of live recombinant viral vector vaccines
de réir: L. M. Khantimirova, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Developing viral vectored vaccines for MAGE-expressing tumours
de réir: McAuliffe, J
Foilsithe / Cruthaithe: (2020)

Baculovirus expression vector system for production of viral vaccines /
de réir: 300419 Vlak, J. M., et al.

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
de réir: Dulce Mata-Espinosa, et al.
Foilsithe / Cruthaithe: (2023-10-01)